title: Standard indication of immunotherapy for the treatment of cancer.
authors.affiliation: Istituto Nazionale per la Ricerca sul Cancro, Genova.
authors.forename: E
authors.initials: E
authors.lastname: Bolli
authors.forename: L
authors.initials: L
authors.lastname: Tixi
authors.forename: A
authors.initials: A
authors.lastname: Mori
authors.forename: A
authors.initials: A
authors.lastname: Guglielmi
authors.forename: C
authors.initials: C
authors.lastname: Aschele
authors.forename: E
authors.initials: E
authors.lastname: Rovini
authors.forename: A
authors.initials: A
authors.lastname: Sobrero
mesh_terms: D006801:Humans; D007167:Immunotherapy; D007372:Interferons / Q000627:therapeutic use; D007978:Levamisole / Q000627:therapeutic use; D009369:Neoplasms / Q000628:therapy*
chemical_list: D007978:Levamisole; D007372:Interferons